TICKERNERD
Menu
PETSPETSHealthcare · Pharmaceutical Retailers

PETS Stock Forecast: PetMed Express, Inc. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$1.98
+1.54% on the day

The 1 Wall Street analysts covering PetMed Express, Inc. hold a median 12-month price target of $2.15 — +8.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 55 of 100 as at 1 Aug 2026 — in the upper half.

Market cap
$42.3M
Ticker Nerd rank
55 / 100
Median analyst target
$2.15
Analysts covering
1
Total return, dividends reinvested
1W
+0.5%
1M
0.0%
YTD
−38.1%
1Y
−38.9%
From 52W high
−49.2%
From 52W low
+23.7%
$1.60
$3.90
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

PETS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores PetMed Express, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
55 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
91
Size
83
Issuance
67
Revisions
62
Quality
45
Momentum
41
Volatility
39
Value
39
Growth
5

Accruals (91): Reported profit is backed by cash, and the company is not expanding recklessly.

Growth (5): Sales and profits are flat, shrinking, or growing more slowly than they were.

The rank is the raw material. Whether the rules would actually own PetMed Express, Inc. — and when they’d sell — is the membership.

Wall Street

PETS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PETS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.50$2.00$2.50$3.00$3.50$4.00Oct 25Jan 26Apr 26Jul 26PETSHigh $2.15Median $2.15Low $2.15

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says1 analysts
0 Buy0 Hold1 Sell
Low $2.15Median $2.15High $2.15

The green dot is the last close — the median target sits +8.6% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
17 Apr 2025Morgan StanleyMaintainsUnderweight$3.50 → $3.20
7 Aug 2024Lake StreetDowngradeHold—
12 June 2024Lake StreetMaintainsBuy—
12 June 2024Morgan StanleyMaintainsUnderweight—
16 Nov 2023Morgan StanleyMaintainsUnderweight—
31 Oct 2023Morgan StanleyMaintainsUnderweight—
19 Oct 2023Morgan StanleyMaintainsUnderweight—
27 July 2023Morgan StanleyReiteratesUnderweight—
25 May 2023Lake StreetInitiatesBuy—
23 Mar 2023Morgan StanleyMaintainsUnderweight—
8 Nov 2022Morgan StanleyMaintainsUnderweight—
26 July 2022Morgan StanleyMaintainsUnderweight—
10 May 2022Morgan StanleyMaintainsUnderweight—
25 Jan 2022Morgan StanleyMaintainsUnderweight—
20 Jan 2022Sidoti & Co.UpgradeBuy—
18 Nov 2021Morgan StanleyInitiatesUnderweight—
1 Oct 2021JefferiesInitiatesHold—
3 June 2021Sidoti & Co.DowngradeNeutral—
5 Mar 2021Sidoti & Co.UpgradeBuy—
19 Aug 2020Sidoti & Co.UpgradeBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

PETS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+600.0%
Analysts raising
1
Analysts cutting
0
Fundamentals

PetMed Express, Inc. (PETS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
257.0×

Cheaper than 3% of US stocks

Price / sales
0.2×

Cheaper than 91% of US stocks

Price / book
1.4×

Cheaper than 57% of US stocks

EV / EBITDA
−1.1×

Cheaper than 68% of US stocks

Growth & margins
Revenue growth (YoY)
−15.6%

Higher than 12% of US stocks

Earnings growth (YoY)
−19.2%

Higher than 20% of US stocks

Gross margin
32.6%

Higher than 40% of US stocks

Operating margin
−9.3%

Higher than 26% of US stocks

Net margin
−32.0%

Higher than 13% of US stocks

Returns & dividend
Return on equity
−100.4%

Higher than 13% of US stocks

Return on assets
−15.4%

Higher than 22% of US stocks

Dividend yield
60.9%

Higher than 97% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

PETS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelPharmaceutical Retailers
CompanyMarket capTKN rank
PETSPetMed Express, Inc.$42.3M
55
SCNXScienture Holdings, Inc.$15.5M
11
HITIHigh Tide, Inc.$185.0M
58
EXOZeXoZymes, Inc.*$43.2M
14
RNXTRenovoRx, Inc.*$43.2M
32
KPTIKaryopharm Therapeutics, Inc.*$43.3M
51
HYPDHyperion DeFi, Inc.*$40.0M
19

* Nearest Healthcare names by size — few pharmaceutical retailers companies of this scale trade in the US universe.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. PETS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest PETS news & analysis

PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026

GlobeNewsWire · 30 July 2026neutral

PetMed Express, Inc. announced it will report its first quarter fiscal year 2027 financial results after market close on Thursday, August 13, 2026, followed by a conference call and webcast at 4:30 p.m. Eastern Time that same day.

Why it matters — The announcement sets the date for the company's next quarterly earnings release, which investors and analysts tracking PETS will watch for updates on financial performance and business trends.

FAQ

Frequently asked questions about PETS stock

What is the PETS stock price forecast for 2026-2027?

The 1 Wall Street analysts covering PetMed Express, Inc. have a median 12-month price target of $2.15, with estimates ranging from $2.15 to $2.15. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is PETS stock a buy right now?

Of the 1 analysts covering PetMed Express, Inc., 0 rate it a Buy, 0 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks PetMed Express, Inc. 55 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank PETS?

As at 1 Aug 2026, PetMed Express, Inc. ranks 55 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (91 of 100).

Will PETS stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +8.6% from the last close, and Ticker Nerd's factor model ranks PetMed Express, Inc. 55 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the PETS stock forecast for 2030?

No analyst covering PetMed Express, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PETS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $2.15 to $2.15 over the next 12 months.

How has PETS stock performed over the past year?

PetMed Express, Inc. returned -38.9% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does PetMed Express, Inc. do?

PetMed Express Inc. is a leading retailer in the pet medication and health products industry.

What is the latest news on PETS?

The most recent item we track (GlobeNewsWire, 30 July 2026): "PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026". PetMed Express, Inc. announced it will report its first quarter fiscal year 2027 financial results after market close on Thursday, August 13, 2026, followed by a conference call and webcast at 4:30 p.m. Eastern Time that same day.

Company

About PetMed Express, Inc.

PetMed Express Inc. is a leading retailer in the pet medication and health products industry. The company specializes in delivering prescription and non-prescription pet medications directly to customers, predominantly serving the pet owners' market in the United States. PetMed Express offers a variety of products for dogs, cats, and small pets, including prescription and non-prescription medications, health supplies, and nutritional supplements. Through its platform, 1-800-PetMeds, it aims to provide pet owners with a convenient, cost-effective alternative to purchasing veterinary medications. The company plays a vital role in the burgeoning pet care industry, which continues to grow as pet ownership becomes more prevalent. Founded in 1996 and headquartered in Florida, PetMed Express frequently emphasizes the importance of accessibility to high-quality pet care products. Its business model combines e-commerce and personalized customer service, positioning itself as a key player in meeting the demands of pet health care in modern lifestyles.

CEO Ms. Leslie C. G. Campbell · 189 employees · United States · https://www.1800petmeds.com